Back to:
NHS Lothian

Think

1. Is the patient unwell?

  • ABCDE approach 

2. Is the result a true value?

  • Could the sampling method have affected the result?
  • Is there a previous level?

3. Does the patient have any symptoms or signs?

  • May indicate the significance and rapidity of electrolyte change
  • Neuromuscular- muscle spasm, weakness, vertigo, ataxia, seizure
  • Bone – osteoporosis/ osteomalacia (chronic only)
  • ECG changes – QRS prolongation, PR prolongation, ventricular arrhythmia

4. Are there culprit drugs? - consider stopping them

  • Alcohol, PPIs, aminoglycosides, amphotericin, ciclosporin, cisplatin, diuretics

5. Causes? - treat them

  • Diarrhoea, intestinal fistula, malabsorption, acute pancreatitis

 

Treat

Care in Myaesthenia Gravis - magnesium replacement can worsen muscle weakness - contact neurology to advise

Severe (Mg2+ < 0.3 mmol/L OR symptoms OR ECG changes)

  • 20 mmol magnesium sulphate (10 ml of 50% magnesium sulphate) in 500 ml 0.9% saline OR 5% dextrose at 21-42 ml per hour (as slow as possible but can be sped up if clinically indicated and discussed with senior).
    reduce dose by 50% if eGFR <25
  • Check Mg2+ at end of infusion
  • Infusion can be repeated daily

Moderate (Mg2+ 0.3-0.7 mmol/L AND asymptomatic)

  • Magnaspartate (10 mmol magnesium per sachet) 1 sachet twice daily for 7 days (NHS Lothian first line)
    OR
    Magnesium glycerophosphate (neomag, 4 mmol magnesium per tablet) 2 tablets three times daily for 7 days (NHS Lothian second line).
    note - contact renal (in working hours) if eGFR <30 - treatment would be off-label but may be appropriate
  • Monitor for side effect of diarrhoea
  • Recheck levels weekly

Note: oral replacement of magnesium can worsen diarrhoea,so if intestinal disruption is thought to be the cause of hypomagnasaemia, consider IV magnesium instead even in moderate hypomagnasaemia

Do I need to Escalate?

Seek senior advice if concerns

Cardiac monitoring or HDU review?

  • Cardiac monitoring needed in severe hypomagnasaemia only if patient a candidate for escalation of care
  • Consider HDU review if significant ECG changes or risk of arrhythmia, particularly if patient is bradycardic or concern regarding heart block